Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase I dose-reduction study of apatinib combined with pemetrexed and carboplatin in untreated EGFR and ALK negative stage IV non-squamous NSCLC.AuthorsHuang, Meijuan; Gong, Youling; Zhu, Jiang; Qin, Yi; Peng, Feng; Ren, Li; Ding, Zhenyu; Liu, Yongmei; Cai, Chengzhi; Wang, Yongsheng; Lu, YouPublicationInvestigational New Drugs, 2020, Vol 38, Issue 2, p478ISSN0167-6997Publication typeArticleDOI10.1007/s10637-019-00811-6